AGED.L vs. BIOT.L
AGED.L (iShares Ageing Population UCITS ETF USD (Acc)) and BIOT.L (L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF) are both exchange-traded funds - AGED.L is a Global Equities fund tracking the Stoxx Global Ageing Population Net USD Index, while BIOT.L is a Health & Biotech Equities fund tracking the Solactive Pharma Breakthrough Value Index Net Total Return. Both are passively managed. Over the past 5 years, AGED.L returned 6.82%/yr vs 2.88%/yr for BIOT.L. A 0.71 correlation means they provide meaningful diversification when combined. AGED.L charges 0.40%/yr vs 0.49%/yr for BIOT.L.
Performance
AGED.L vs. BIOT.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AGED.L achieves a 11.60% return, which is significantly higher than BIOT.L's 8.52% return.
AGED.L
- 1D
- 0.38%
- 1M
- 5.74%
- 6M
- 9.20%
- YTD
- 11.60%
- 1Y
- 26.99%
- 3Y*
- 15.90%
- 5Y*
- 6.82%
- 10Y*
- —
BIOT.L
- 1D
- 0.54%
- 1M
- 8.76%
- 6M
- 9.00%
- YTD
- 8.52%
- 1Y
- 34.12%
- 3Y*
- 10.28%
- 5Y*
- 2.88%
- 10Y*
- —
AGED.L vs. BIOT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AGED.L iShares Ageing Population UCITS ETF USD (Acc) | 11.60% | 26.75% | 7.86% | 9.03% | -14.29% | 4.61% | 13.29% | 19.47% | -16.30% |
BIOT.L L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF | 8.52% | 36.47% | -5.31% | -9.28% | -8.41% | -3.60% | 28.29% | 13.02% | -8.12% |
Correlation
The correlation between AGED.L and BIOT.L is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.63 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.65 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.72 |
Correlation (All Time) Calculated using the full available price history since Jan 18, 2018 | 0.71 |
The correlation between AGED.L and BIOT.L has been stable across timeframes, ranging from 0.63 to 0.72 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AGED.L vs. BIOT.L — Risk / Return Rank
AGED.L
BIOT.L
AGED.L vs. BIOT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Ageing Population UCITS ETF USD (Acc) (AGED.L) and L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AGED.L | BIOT.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.07 | ||
| Sortino ratioReturn per unit of downside risk | +0.16 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.28 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 3.20 | 3.56 | -0.36 |
| Martin ratioReturn relative to average drawdown | 11.64 | 10.22 | +1.42 |
Loading charts...
Drawdowns
AGED.L vs. BIOT.L - Drawdown Comparison
The maximum AGED.L drawdown since its inception was -40.12%, which is greater than BIOT.L's maximum drawdown of -34.44%. Use the drawdown chart below to compare losses from any high point for AGED.L and BIOT.L.
Loading charts...
Drawdown Indicators
| AGED.L | BIOT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.12% | -34.44% | -5.68% |
Max Drawdown (1Y)Largest decline over 1 year | -8.40% | -9.55% | +1.15% |
Max Drawdown (3Y)Largest decline over 3 years | -16.38% | -19.91% | +3.53% |
Max Drawdown (5Y)Largest decline over 5 years | -27.68% | -33.80% | +6.12% |
Current DrawdownCurrent decline from peak | -0.65% | -5.50% | +4.85% |
Average DrawdownAverage peak-to-trough decline | -8.54% | -13.31% | +4.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.31% | 3.33% | -1.02% |
Volatility
AGED.L vs. BIOT.L - Volatility Comparison
The current volatility for iShares Ageing Population UCITS ETF USD (Acc) (AGED.L) is 3.75%, while L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) has a volatility of 6.09%. This indicates that AGED.L experiences smaller price fluctuations and is considered to be less risky than BIOT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AGED.L | BIOT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.75% | 6.09% | -2.34% |
Volatility (6M)Calculated over the trailing 6-month period | 12.23% | 15.55% | -3.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.33% | 20.19% | -4.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.78% | 18.63% | -0.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.74% | 19.50% | -1.76% |
AGED.L vs. BIOT.L - Expense Ratio Comparison
AGED.L has a 0.40% expense ratio, which is lower than BIOT.L's 0.49% expense ratio.
Dividends
AGED.L vs. BIOT.L - Dividend Comparison
Neither AGED.L nor BIOT.L has paid dividends to shareholders.
Frequently Asked Questions
AGED.L and BIOT.L have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, AGED.L is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
AGED.L is cheaper with a 0.40% expense ratio, compared with 0.49% for BIOT.L.
AGED.L is categorized as Global Equities, while BIOT.L is Health & Biotech Equities. AGED.L tracks Stoxx Global Ageing Population Net USD Index, while BIOT.L tracks Solactive Pharma Breakthrough Value Index Net Total Return. They also come from different issuers: iShares and L&G. Their fees differ too: 0.40% for AGED.L and 0.49% for BIOT.L.
Find the right allocation for AGED.L and BIOT.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer